Answers are grounded in this paper and cite their sources.
BACKGROUND: R device compared with two existing gas exchangers. METHODS: removal device (blood gas analysis method). RESULTS: removal. The resistance to blood flow across the test device, as measured by pressure drop, varied as a function of blood flow rate, and was greatest for PrismaLung and lowest for the A.L.ONE device. CONCLUSIONS: removal comparable to A.L.ONE at the flow rates tested, despite the smaller membrane surface area of PrismaLung+ versus A.L.ONE. Clinical testing of PrismaLung+ is warranted to further characterize its performance.
No takes yet. Share an insight, caveat, or question.
Hospach et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: